about
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudil...
Read More
3.30
-0.02
(-0.60%)
666.9K
XNAS Volume
High vol.+gain this week
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Medicinova Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..